Matches in Nanopublications for { ?s ?p "[We have studied immunological features of 200 cases of acute leukemia (109 acute myelogenous leukemia, AML, and 91 acute lymphoblastic leukemia, ALL, according to FAB criteria), including 17 (8.5%) classified as biphenotypic by a scoring system based on the number and specificity of unexpected lineage antigens and which gives more weight to cytoplasmic markers such as myeloperoxidase, CD3, and CD22, and less to other membrane markers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 14 of
14
with 100 items per page.
- NP279890.RAcHgw21hcCCODMEWabKUin5QTgc68aycdoKQ02r6tFp8130_assertion description "[We have studied immunological features of 200 cases of acute leukemia (109 acute myelogenous leukemia, AML, and 91 acute lymphoblastic leukemia, ALL, according to FAB criteria), including 17 (8.5%) classified as biphenotypic by a scoring system based on the number and specificity of unexpected lineage antigens and which gives more weight to cytoplasmic markers such as myeloperoxidase, CD3, and CD22, and less to other membrane markers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP279890.RAcHgw21hcCCODMEWabKUin5QTgc68aycdoKQ02r6tFp8130_provenance.
- NP548646.RABkKFSSlPE9-2cjCormeAC5zdOdfWbSSimD5fTt0Ph28130_assertion description "[We have studied immunological features of 200 cases of acute leukemia (109 acute myelogenous leukemia, AML, and 91 acute lymphoblastic leukemia, ALL, according to FAB criteria), including 17 (8.5%) classified as biphenotypic by a scoring system based on the number and specificity of unexpected lineage antigens and which gives more weight to cytoplasmic markers such as myeloperoxidase, CD3, and CD22, and less to other membrane markers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP548646.RABkKFSSlPE9-2cjCormeAC5zdOdfWbSSimD5fTt0Ph28130_provenance.
- NP199425.RApxZustK150CeWBVYdG0rKMJRX6Sy-dfey5wReBU5dXU130_assertion description "[We have studied immunological features of 200 cases of acute leukemia (109 acute myelogenous leukemia, AML, and 91 acute lymphoblastic leukemia, ALL, according to FAB criteria), including 17 (8.5%) classified as biphenotypic by a scoring system based on the number and specificity of unexpected lineage antigens and which gives more weight to cytoplasmic markers such as myeloperoxidase, CD3, and CD22, and less to other membrane markers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP199425.RApxZustK150CeWBVYdG0rKMJRX6Sy-dfey5wReBU5dXU130_provenance.
- NP314758.RAiA2k0dbmKtfAu2hP8sSbSWVfeQ2MhvSTlTHVkQx0Kvo130_assertion description "[We have studied immunological features of 200 cases of acute leukemia (109 acute myelogenous leukemia, AML, and 91 acute lymphoblastic leukemia, ALL, according to FAB criteria), including 17 (8.5%) classified as biphenotypic by a scoring system based on the number and specificity of unexpected lineage antigens and which gives more weight to cytoplasmic markers such as myeloperoxidase, CD3, and CD22, and less to other membrane markers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP314758.RAiA2k0dbmKtfAu2hP8sSbSWVfeQ2MhvSTlTHVkQx0Kvo130_provenance.
- NP361067.RArzMAh_Q0RsB9ncIDKxBI9CaQ4VVrm-tcd4rMEKvnt3k130_assertion description "[We have studied immunological features of 200 cases of acute leukemia (109 acute myelogenous leukemia, AML, and 91 acute lymphoblastic leukemia, ALL, according to FAB criteria), including 17 (8.5%) classified as biphenotypic by a scoring system based on the number and specificity of unexpected lineage antigens and which gives more weight to cytoplasmic markers such as myeloperoxidase, CD3, and CD22, and less to other membrane markers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP361067.RArzMAh_Q0RsB9ncIDKxBI9CaQ4VVrm-tcd4rMEKvnt3k130_provenance.
- NP546500.RAmQpzZ6aDnmEIGHNOjC2h6resBfDmZMgqaVw_gEUvFFM130_assertion description "[We have studied immunological features of 200 cases of acute leukemia (109 acute myelogenous leukemia, AML, and 91 acute lymphoblastic leukemia, ALL, according to FAB criteria), including 17 (8.5%) classified as biphenotypic by a scoring system based on the number and specificity of unexpected lineage antigens and which gives more weight to cytoplasmic markers such as myeloperoxidase, CD3, and CD22, and less to other membrane markers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP546500.RAmQpzZ6aDnmEIGHNOjC2h6resBfDmZMgqaVw_gEUvFFM130_provenance.
- NP697764.RAjXslShuqCdy1KfgeK9wwMge4qiAVGYz8BnK8pkK6lg8130_assertion description "[We have studied immunological features of 200 cases of acute leukemia (109 acute myelogenous leukemia, AML, and 91 acute lymphoblastic leukemia, ALL, according to FAB criteria), including 17 (8.5%) classified as biphenotypic by a scoring system based on the number and specificity of unexpected lineage antigens and which gives more weight to cytoplasmic markers such as myeloperoxidase, CD3, and CD22, and less to other membrane markers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP697764.RAjXslShuqCdy1KfgeK9wwMge4qiAVGYz8BnK8pkK6lg8130_provenance.
- assertion description "[We have studied immunological features of 200 cases of acute leukemia (109 acute myelogenous leukemia, AML, and 91 acute lymphoblastic leukemia, ALL, according to FAB criteria), including 17 (8.5%) classified as biphenotypic by a scoring system based on the number and specificity of unexpected lineage antigens and which gives more weight to cytoplasmic markers such as myeloperoxidase, CD3, and CD22, and less to other membrane markers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP394400.RATEZw3qHzruYT3lazdAVcUQsP-hMoHfDbnHYtSveEiqs130_assertion description "[We have studied immunological features of 200 cases of acute leukemia (109 acute myelogenous leukemia, AML, and 91 acute lymphoblastic leukemia, ALL, according to FAB criteria), including 17 (8.5%) classified as biphenotypic by a scoring system based on the number and specificity of unexpected lineage antigens and which gives more weight to cytoplasmic markers such as myeloperoxidase, CD3, and CD22, and less to other membrane markers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP394400.RATEZw3qHzruYT3lazdAVcUQsP-hMoHfDbnHYtSveEiqs130_provenance.
- assertion description "[We have studied immunological features of 200 cases of acute leukemia (109 acute myelogenous leukemia, AML, and 91 acute lymphoblastic leukemia, ALL, according to FAB criteria), including 17 (8.5%) classified as biphenotypic by a scoring system based on the number and specificity of unexpected lineage antigens and which gives more weight to cytoplasmic markers such as myeloperoxidase, CD3, and CD22, and less to other membrane markers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP291263.RAwQOgOaCa-kplHf0pIBVV9VMpoTHWVfo5sKzWttaU7lM130_assertion description "[We have studied immunological features of 200 cases of acute leukemia (109 acute myelogenous leukemia, AML, and 91 acute lymphoblastic leukemia, ALL, according to FAB criteria), including 17 (8.5%) classified as biphenotypic by a scoring system based on the number and specificity of unexpected lineage antigens and which gives more weight to cytoplasmic markers such as myeloperoxidase, CD3, and CD22, and less to other membrane markers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP291263.RAwQOgOaCa-kplHf0pIBVV9VMpoTHWVfo5sKzWttaU7lM130_provenance.
- NP1343465.RAJMr2FjaeocWXqwud5acyqw05iaFC9zC5JIlnplMow0I130_assertion description "[We have studied immunological features of 200 cases of acute leukemia (109 acute myelogenous leukemia, AML, and 91 acute lymphoblastic leukemia, ALL, according to FAB criteria), including 17 (8.5%) classified as biphenotypic by a scoring system based on the number and specificity of unexpected lineage antigens and which gives more weight to cytoplasmic markers such as myeloperoxidase, CD3, and CD22, and less to other membrane markers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1343465.RAJMr2FjaeocWXqwud5acyqw05iaFC9zC5JIlnplMow0I130_provenance.
- NP1343467.RAJg7kYFjU6o_GhqFFf0sEA6QTeF6rh3bYox7UKZF-X60130_assertion description "[We have studied immunological features of 200 cases of acute leukemia (109 acute myelogenous leukemia, AML, and 91 acute lymphoblastic leukemia, ALL, according to FAB criteria), including 17 (8.5%) classified as biphenotypic by a scoring system based on the number and specificity of unexpected lineage antigens and which gives more weight to cytoplasmic markers such as myeloperoxidase, CD3, and CD22, and less to other membrane markers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1343467.RAJg7kYFjU6o_GhqFFf0sEA6QTeF6rh3bYox7UKZF-X60130_provenance.
- NP1343466.RA-Y3SHipluid-Dvp9V8DZoKwCZk7HaC52QlwzfKQnaec130_assertion description "[We have studied immunological features of 200 cases of acute leukemia (109 acute myelogenous leukemia, AML, and 91 acute lymphoblastic leukemia, ALL, according to FAB criteria), including 17 (8.5%) classified as biphenotypic by a scoring system based on the number and specificity of unexpected lineage antigens and which gives more weight to cytoplasmic markers such as myeloperoxidase, CD3, and CD22, and less to other membrane markers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1343466.RA-Y3SHipluid-Dvp9V8DZoKwCZk7HaC52QlwzfKQnaec130_provenance.